Profilo
Noreen Roth Henig is currently an Independent Director at Lazard Healthcare Acquisition Corp.
I.
Former positions include Independent Director at Avidity Biosciences, Inc. (2019–2026), Independent Director at Lazard Growth Acquisition Corp.
I (2021–2023), Chief Medical Officer at Kezar Life Sciences, Inc. (2020–2023), Chief Medical Officer at Breath Therapeutics GmbH (2018–2020), Chief Development Officer at ProQR Therapeutics NV (2014–2017), Senior Director-Global Respiratory at Gilead Sciences, Inc. (2011–2014), and Director-Adult Cystic Fibrosis Care Centers at Cystic Fibrosis Foundation (1999–2008).
Education includes an undergraduate degree from Yale University (1987) and a doctorate from Albert Einstein College of Medicine, Inc. (1991).
Posizioni attive di Noreen Henig
| Società | Posizione | Inizio |
|---|---|---|
Lazard Healthcare Acquisition Corp. I
Lazard Healthcare Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Noreen Henig
| Società | Posizione | Fine |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 27/02/2026 |
| KEZAR LIFE SCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 06/10/2023 |
| LAZARD GROWTH ACQUISITION CORP. I | Direttore/Membro del Consiglio | 01/02/2023 |
Breath Therapeutics GmbH
Breath Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops inhalation drug therapies for severe respiratory diseases | Direttore Tecnico/Scientifico/R&S | 01/03/2020 |
| PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 01/11/2017 |
Formazione di Noreen Henig
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Avidity Biosciences, Inc.
Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation Miscellaneous Commercial ServicesCommercial Services Provides healthcare services and programs | Commercial Services |
Albert Einstein College of Medicine, Inc.
Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProQR Therapeutics NV
ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Breath Therapeutics GmbH
Breath Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops inhalation drug therapies for severe respiratory diseases | Health Technology |
Lazard Growth Acquisition Corp. I
Lazard Growth Acquisition Corp. I SemiconductorsElectronic Technology Operates as a blank check company | Electronic Technology |
Lazard Healthcare Acquisition Corp. I
Lazard Healthcare Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
















